Shanghai Haohai Biological Technology Co., Ltd. 5HB.F Stock
Shanghai Haohai Biological Technology Co., Ltd. Price Chart
Shanghai Haohai Biological Technology Co., Ltd. 5HB.F Financial and Trading Overview
Contents
- Shanghai Haohai Biological Technology Co., Ltd. Price Chart
- Shanghai Haohai Biological Technology Co., Ltd. 5HB.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Haohai Biological Technology Co., Ltd.
- Q&A For Shanghai Haohai Biological Technology Co., Ltd. Stock
Shanghai Haohai Biological Technology Co., Ltd. stock price | 4.8 EUR |
Previous Close | 3.84 EUR |
Open | 4 EUR |
Bid | 3.8 EUR x 52200 |
Ask | 3.98 EUR x 50000 |
Day's Range | 4 - 4 EUR |
52 Week Range | 2.64 - 5.3 EUR |
Volume | 233 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.72B EUR |
Beta (5Y Monthly) | 1.022988 |
PE Ratio (TTM) | 30.769232 |
EPS (TTM) | 0.33 EUR |
Forward Dividend & Yield | 0.05 (1.37%) |
Ex-Dividend Date | July 4, 2023 |
1y Target Est | N/A |
5HB.F Valuation Measures
Enterprise Value | -1364556672 EUR |
Trailing P/E | 30.769232 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.76049376 |
Price/Book (mrq) | 0.12528189 |
Enterprise Value/Revenue | -0.602 |
Enterprise Value/EBITDA | -3.431 |
Trading Information
Shanghai Haohai Biological Technology Co., Ltd. Stock Price History
Beta (5Y Monthly) | 1.022988 |
52-Week Change | -10.0000024% |
S&P500 52-Week Change | 20.43% |
52 Week High | 5.3 EUR |
52 Week Low | 2.64 EUR |
50-Day Moving Average | 4.55 EUR |
200-Day Moving Average | 4.15 EUR |
5HB.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 33.47M |
Float | 65.4M |
Short Ratio | N/A |
% Held by Insiders | 0.021% |
% Held by Institutions | 25.56% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.4 |
Trailing Annual Dividend Yield | 10.41% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.67870003 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.84% |
Operating Margin (ttm) | 9.40% |
Gross Margin | 69.33% |
EBITDA Margin | 17.53% |
Management Effectiveness
Return on Assets (ttm) | 1.92% |
Return on Equity (ttm) | 3.55% |
Income Statement
Revenue (ttm) | 2.27B EUR |
Revenue Per Share (ttm) | 13.1 EUR |
Quarterly Revenue Growth (yoy) | 29.09% |
Gross Profit (ttm) | N/A |
EBITDA | 397.73M EUR |
Net Income Avi to Common (ttm) | 200.71M EUR |
Diluted EPS (ttm) | 0.13 |
Quarterly Earnings Growth (yoy) | 33.20% |
Balance Sheet
Total Cash (mrq) | 2.61B EUR |
Total Cash Per Share (mrq) | 15.1 EUR |
Total Debt (mrq) | 197.79M EUR |
Total Debt/Equity (mrq) | 3.35 EUR |
Current Ratio (mrq) | 6.993 |
Book Value Per Share (mrq) | 31.928 |
Cash Flow Statement
Operating Cash Flow (ttm) | 306.76M EUR |
Levered Free Cash Flow (ttm) | -31969520 EUR |
Profile of Shanghai Haohai Biological Technology Co., Ltd.
Country | Germany |
State | N/A |
City | Shanghai |
Address | WenGuang Plaza |
ZIP | N/A |
Phone | 86 21 5229 3555 |
Website | https://www.3healthcare.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1990 |
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, scalpels, etc.; orthopedics products, such as sodium hyaluronate injection and medical chitosan; wound repair products, including recombinant human epidermal growth factor for the treatment of burn wound, residual wound, donor site posttraumatic wound, and fresh or old wound of chronic ulcer; anti-adhesion materials comprising medical sodium hyaluronate gel and medical chitosan; and hemostatic materials, such as collagen sponge and porcine fibrin sealants. The company also provides medical aesthetics products comprising Matrifill, a first-generation HA dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; and radio frequency devices and laser equipment. In addition, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; and investment and trading business. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Q&A For Shanghai Haohai Biological Technology Co., Ltd. Stock
What is a current 5HB.F stock price?
Shanghai Haohai Biological Technology Co., Ltd. 5HB.F stock price today per share is 4.8 EUR.
How to purchase Shanghai Haohai Biological Technology Co., Ltd. stock?
You can buy 5HB.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Haohai Biological Technology Co., Ltd.?
The stock symbol or ticker of Shanghai Haohai Biological Technology Co., Ltd. is 5HB.F.
Which industry does the Shanghai Haohai Biological Technology Co., Ltd. company belong to?
The Shanghai Haohai Biological Technology Co., Ltd. industry is Biotechnology.
How many shares does Shanghai Haohai Biological Technology Co., Ltd. have in circulation?
The max supply of Shanghai Haohai Biological Technology Co., Ltd. shares is 373.05M.
What is Shanghai Haohai Biological Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Haohai Biological Technology Co., Ltd. PE Ratio is 14.54545500 now.
What was Shanghai Haohai Biological Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Haohai Biological Technology Co., Ltd. EPS is 0.33 EUR over the trailing 12 months.
Which sector does the Shanghai Haohai Biological Technology Co., Ltd. company belong to?
The Shanghai Haohai Biological Technology Co., Ltd. sector is Healthcare.